Xue-jun Yang
Tianjin, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Journal: Disease markers
Published: December 08, 2020
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.
Journal: Chinese medical journal
Published: October 21, 2015
Relationship between Golgi apparatus and cell migration direction in vivo and in vitro
Journal: Zhonghua yi xue za zhi
Published: October 31, 2013
Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.
Journal: Chinese medical journal
Published: December 21, 2012
Glioma stem cells enhanced angiogenesis and its relationship with microvessel
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: August 14, 2012
Role of Rac1 in the SDF-1-induced migration and invasion of human glioma cell line U251
Journal: Zhonghua yi xue za zhi
Published: July 12, 2012
Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
Journal: Chinese medical journal
Published: November 02, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026